PATH

Conclusions

• 🟢Price vs. SMA 50 — Price is above the 50-day average
• 🟢Price vs. SMA 200 — Price is above the 200-day average
• 🟢MACD — MACD histogram is positive — rising momentum
• 🟢RSI — RSI 67.6 — healthy positive momentum
• 🔴Stochastic — %K 87.9 — overbought
• 🟡ADX (trend strength) — ADX 16.5 — weak trend/choppy
• 🔴Volume trend — Volume is falling despite the price advance — possible weakening
• 🟢Relative strength vs. S&P 500 — +24.4% over the last 3 months relative to the index
• 🟢Bollinger Bands — Price is in the upper third of the Bollinger Bands (98%B) — strong momentum (risk of a pullback)
• 🟢ROC (rate of change) — ROC 12 days: 13.7%
• 🟢Parabolic SAR — Price is above the SAR point — uptrend
• 🟢CMF (money flow) — CMF 20 days: 0.08

3️⃣ Suggested Exit Point (ATR-based)

Method formula: Stop-loss = support minusone ATR margin — this way the stop adapts to the stock's actual volatility, rather than an arbitrary number.

Profit Targets by Risk/Reward Ratio (R)

Conclusions

• 🟢Gross margin — Gross margin: 83.2% — strong
• 🔴Operating margin — Operating margin: 3.5% — weak
• 🟢Net margin — Net margin: 17.5% — strong
• 🟡Return on equity (ROE) — Return on equity (ROE): 13.6% — reasonable
• 🟡Return on assets (ROA) — Return on assets (ROA): 8.9% — reasonable
• 🟢Current ratio (liquidity) — Current ratio: 2.48

Conclusions

• 🟢Revenue growth (last year) — Revenue growth (last year): 12.7%
• 🟢Earnings per share (EPS) growth — Earnings per share (EPS) growth: 500.0%
• 🟢Free cash flow growth — Free cash flow growth: 15.2%
• 🟢Net income growth — Net income growth: 483.1%

Conclusions

• 🟡DCF Fair Value — Estimated fair value: $13.48 vs. price $14.00 (-3.7%)
• 🟡Tangible Net Asset Value (NAV) — NAV per share: $3.56
• 🟡P/E — P/E: 26.6